Gene · 684
Papers3,814
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 3,814
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The interplay between lncRNAs, RNA-binding proteins and viral genome during SARS-CoV-2 infection reveals strong connections with regulatory events involved in RNA metabolism and immune response. | Theranostics | 2022 | 35664076 | PubTator, text mining | PubMed |
| Establishment and Verification of a Gene Signature for Diagnosing Type 2 Diabetics by WGCNA, LASSO Analysis, and In Vitro Experiments. | Biomed Res Int | 2022 | 35655479 | PubTator, text mining | PubMed |
| The nonstructural p17 protein of a fusogenic bat-borne reovirus regulates viral replication in virus species- and host-specific manners. | PLoS Pathog | 2022 | 35653397 | PubTator, text mining | PubMed |
| Remodeling the tumor microenvironment by oncolytic viruses: beyond oncolysis of tumor cells for cancer treatment. | J Immunother Cancer | 2022 | 35640930 | PubTator, text mining | PubMed |
| Bone marrow stromal cell antigen 2(BST2) suppresses the migration and invasion of trophoblasts in preeclampsia by downregulating matrix metallopeptidase 2(MMP2). | Bioengineered | 2022 | 35635087 | PubTator, text mining | PubMed |
| Antiviral Activities of Interleukin-27: A Partner for Interferons? | Front Immunol | 2022 | 35634328 | PubTator, text mining | PubMed |
| High Expression of HERV-K (HML-2) Might Stimulate Interferon in COVID-19 Patients. | Viruses | 2022 | 35632738 | PubTator, text mining | PubMed |
| Flavivirus Capsid Proteins Inhibit the Interferon Response. | Viruses | 2022 | 35632712 | PubTator, text mining | PubMed |
| Ginkgo Biloba Leaf Extract Improves an Innate Immune Response of Peripheral Blood Leukocytes of Alzheimer's Disease Patients. | Nutrients | 2022 | 35631163 | PubTator, text mining | PubMed |
| The Evolutionary Dance between Innate Host Antiviral Pathways and SARS-CoV-2. | Pathogens | 2022 | 35631059 | PubTator, text mining | PubMed |
| Current Knowledge on Exosome Biogenesis, Cargo-Sorting Mechanism and Therapeutic Implications. | Membranes (Basel) | 2022 | 35629824 | PubTator, text mining | PubMed |
| PepNN: a deep attention model for the identification of peptide binding sites. | Commun Biol | 2022 | 35618814 | PubTator, text mining | PubMed |
| SARS-CoV-2 ORF7a potently inhibits the antiviral effect of the host factor SERINC5. | Nat Commun | 2022 | 35618710 | PubTator, text mining | PubMed |
| Identification of HIV-reservoir cells with reduced susceptibility to antibody-dependent immune response. | Elife | 2022 | 35616530 | PubTator, text mining | PubMed |
| Signaling events evoked by domain III of envelop glycoprotein of tick-borne encephalitis virus and West Nile virus in human brain microvascular endothelial cells. | Sci Rep | 2022 | 35614140 | PubTator, text mining | PubMed |
| Editorial overview: 2022 "Virus-Host Interaction" section of Current Opinion in Virology. | Curr Opin Virol | 2022 | 35613537 | PubTator, text mining | PubMed |
| ALTEN: A High-Fidelity Primary Tissue-Engineering Platform to Assess Cellular Responses Ex Vivo. | Adv Sci (Weinh) | 2022 | 35611998 | PubTator, text mining | PubMed |
| RNA-Seq of amniotic fluid cell-free RNA: a discovery phase study of the pathophysiology of congenital cytomegalovirus infection. | Am J Obstet Gynecol | 2022 | 35609640 | PubTator, text mining | PubMed |
| Host Restrictive Factors Are the Emerging Storm Troopers Against Enterovirus: A Mini-Review. | Front Immunol | 2022 | 35603180 | PubTator, text mining | PubMed |
| Proteomic Alterations and Novel Markers of Neurotoxic Reactive Astrocytes in Human Induced Pluripotent Stem Cell Models. | Front Mol Neurosci | 2022 | 35592112 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/684/papers?page=39